KBC Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.88M Sell
54,005
-357
-0.7% -$32.8K 0.01% 481
2025
Q4
$4.89M Buy
54,362
+26,302
+94% +$2.49M 0.01% 464
2025
Q3
$2.76M Buy
28,060
+154
+0.6% +$15.3K 0.01% 539
2025
Q2
$2.54M Sell
27,906
-834
-3% -$80.6K 0.01% 545
2025
Q1
$3.25M Sell
28,740
-524
-2% -$56.1K 0.01% 521
2024
Q4
$3.09M Buy
29,264
+3,977
+16% +$427K 0.01% 600
2024
Q3
$2.73M Buy
25,287
+9,864
+64% +$1.08M 0.01% 567
2024
Q2
$1.67M Sell
15,423
-5,186
-25% -$611K 0.01% 612
2024
Q1
$2.72M Sell
20,609
-8,445
-29% -$1.05M 0.01% 547
2023
Q4
$3.54M Sell
29,054
-35,712
-55% -$3.98M 0.01% 516
2023
Q3
$7.27M Sell
64,766
-25,874
-29% -$3.29M 0.03% 398
2023
Q2
$13.2M Buy
90,640
+1,686
+2% +$229K 0.05% 294
2023
Q1
$11.5M Buy
88,954
+52,475
+144% +$6.59M 0.05% 326
2022
Q4
$4.65M Buy
36,479
+23,459
+180% +$2.72M 0.02% 438
2022
Q3
$1.36M Sell
13,020
-72
-0.5% -$7.9K 0.01% 617
2022
Q2
$1.38M Buy
13,092
+365
+3% +$43.3K 0.01% 607
2022
Q1
$1.63M Sell
12,727
-382
-3% -$46K 0.01% 621
2021
Q4
$1.62M Sell
13,109
-13,395
-51% -$1.75M 0.01% 640
2021
Q3
$3.77M Sell
26,504
-49,656
-65% -$7.3M 0.01% 530
2021
Q2
$11.9M Buy
76,160
+30,529
+67% +$4.95M 0.02% 455
2021
Q1
$7.09M Hold
45,631
0.01% 534
2020
Q4
$37.5M Hold
45,631
0.02% 535
2020
Q3
$6.03M Hold
45,631
0.02% 510
2020
Q2
$5.29M Sell
45,631
-63,932
-58% -$7.37M 0.02% 507
2020
Q1
$10.8M Buy
109,563
+34,963
+47% +$4.58M 0.09% 231
2019
Q4
$10.8M Sell
74,600
-30,933
-29% -$4.27M 0.07% 308
2019
Q3
$14.1M Sell
105,533
-65,034
-38% -$8.4M 0.1% 243
2019
Q2
$19.5M Buy
170,567
+22,609
+15% +$2.65M 0.15% 173
2019
Q1
$18.3M Buy
147,958
+26,428
+22% +$3M 0.15% 175
2018
Q4
$12.2M Buy
121,530
+90,919
+297% +$10.2M 0.14% 193
2018
Q3
$3.91M Buy
30,611
+14,773
+93% +$1.76M 0.03% 490
2018
Q2
$1.71M Hold
15,838
0.01% 646
2018
Q1
$1.68M Sell
15,838
-2,664
-14% -$309K 0.02% 616
2017
Q4
$2.17M Sell
18,502
-3,639
-16% -$411K 0.02% 584
2017
Q3
$2.52M Buy
22,141
+1,369
+7% +$158K 0.02% 551
2017
Q2
$2.59M Buy
20,772
+2,222
+12% +$263K 0.03% 521
2017
Q1
$2.2M Sell
18,550
-8,413
-31% -$954K 0.02% 619
2016
Q4
$2.7M Buy
26,963
+1,462
+6% +$157K 0.03% 555
2016
Q3
$3.22M Sell
25,501
-1,297
-5% -$160K 0.04% 454
2016
Q2
$3.13M Sell
26,798
-294
-1% -$33.3K 0.04% 429
2016
Q1
$2.81M Sell
27,092
-43,186
-61% -$4.18M 0.05% 419
2015
Q4
$7M Buy
70,278
+4,810
+7% +$471K 0.13% 191
2015
Q3
$5.97M Sell
65,468
-15,045
-19% -$1.51M 0.12% 217
2015
Q2
$8.54M Buy
80,513
+19,494
+32% +$2.16M 0.11% 232
2015
Q1
$6.96M Sell
61,019
-21,818
-26% -$2.49M 0.09% 258
2014
Q4
$9.12M Buy
82,837
+72,137
+674% +$7.6M 0.11% 225
2014
Q3
$1.04M Sell
10,700
-7,659
-42% -$753K 0.04% 502
2014
Q2
$1.85M Buy
18,359
+5,916
+48% +$577K 0.02% 607
2014
Q1
$1.14M Sell
12,443
-3,869
-24% -$357K 0.02% 627
2013
Q4
$1.48M Sell
16,312
-15,196
-48% -$1.31M 0.02% 590
2013
Q3
$2.51M Sell
31,508
-13,694
-30% -$1.08M 0.04% 456
2013
Q2
$3.29M Buy
+45,202
New +$3.38M 0.06% 373

Other funds holding ZBH

KBC Group's ZBH Position: Q1 2026 in Review

KBC Group reduced its Zimmer Biomet (ZBH) stake by 0.66% in Q1 2026, selling an estimated $32.8K and leaving 54,005 shares worth $4.88M. The position accounts for 0.01% of the portfolio, ranked #481.

KBC Group first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.5M in Q4 2020. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • KBC Group held 54,005 shares of Zimmer Biomet worth $4.88M as of Q1 2026.
  • KBC Group sold 357 Zimmer Biomet shares in Q1 2026, an estimated $32.8K.
  • Zimmer Biomet made up 0.01% of KBC Group's portfolio in Q1 2026, its #481 holding.
  • KBC Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's Zimmer Biomet position peaked at $37.5M in Q4 2020.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.